Aptus Pharma Preferential Issue

Aptus Pharma Preferential Issue

Aptus Pharma got BSE in-principle approval for a preferential issue of 15,99,270 shares at a minimum Rs. 280 each. The issue is worth about Rs. 44.78 Crore.

Value

₹44.78 Cr

Aptus Pharma Investor Presentation: Key Takeaways

H1 FY27 revenue ₹48.92 Cr, EBITDA ₹7.68 Cr (15.7% margin), PAT ₹5.07 Cr; revenue exceeds full FY26 (₹46.57 Cr). Trading-heavy model with rising receivables and negative operating cash flow.

Aptus Pharma H1 FY27 Results: Net Profit ₹5.1 Cr, Up 200.0% YoY

Aptus Pharma Ltd reported revenue from operations of ₹48.9 Cr (+239.6% YoY) and net profit of ₹5.1 Cr (+200.0% YoY) for H1 FY27.

Key figure

Net profit ₹5.1 Cr · +200.0% YoY

Aptus Pharma Other Announcement

Aptus Pharma Limited submitted the Regulation 74(5) compliance certificate for the quarter and half-year ended 30th September 2026, as received from its registrar.

Aptus Pharma Annual General Meeting

Aptus Pharma Ltd issued a corrigendum to its 16th AGM notice regarding inadvertent errors in the explanatory statement for item no. 3.

Aptus Pharma Fund Raise of ₹44.88 Cr

Aptus Pharma Limited's Board has approved raising ₹44.88 Crore through a preferential equity issue. Funds will support manufacturing capacity expansion, working capital, and Pan-India growth initiatives.

Value

₹44.88 Cr

Execution

36 months

Kirloskar Electric Company Preferential Issue

KECL received BSE and NSE listing approvals for 34,68,007 preferential issue shares to Kirloskar Power Equipments Limited. The issue value is approximately ₹40 Crore.

Value

₹40.00 Cr

Yatharth Hospital & Trauma Care Services Preferential Issue

Yatharth Hospital received CCI approval for its proposed ₹3,150 Crore preferential issue to Rasmalai Limited (24.87% stake). This clears a key regulatory hurdle for the capital raise.

Value

₹3,150 Cr

IIFL Finance Preferential Issue

IIFL Finance's EGM on 4 December 2026 seeks approval for a preferential issue. Convertible preference shares and warrants total about ₹6,414.20 Crore.

Value

₹6,414 Cr

Natural Capsules Preferential Issue

Natural Capsules added an allotment of 1,12,500 equity shares and 4,50,000 warrants to promoter Sunil Mundra to its 13 November board agenda. No issue price is stated.

IIFL Finance Preferential Issue

IIFL Finance executed three subscription agreements for a preferential issue of CCPS and warrants at Rs 602 per share. Completion is subject to shareholder and regulatory approvals.

Simplex Infrastructures Preferential Issue

Simplex Infrastructures submitted the CARE Ratings monitoring agency report for the quarter ended 30 September 2026 on its preferential issue. The report shows nil deviation from objects, with the issue aggregating Rs.423.69 crore.